Evaluation of phenylboronate agarose for industrial-scale purification of erythropoietin from mammalian cell cultures

Dino Zanette, Adolfo Soffientini, Cristina Sottani, Edoardo Sarubbi

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The search for novel, cost-effective ways to produce erythropoietin (Epo), the world top-selling biopharmaceutical, is a major challenge for today's biotechnology industry. However, Epo's high glycosylation content (almost 40% of total mass) and the requirement for sialic acid for optimal in vivo activity still make mammalian cells the expression system of choice. In contrast to the abundance of reports on Epo production, robust, cost-effective methods for large-scale Epo purification can hardly be found in literature. To fill this gap, we describe here a process specifically studied for industrial-scale purification of the protein. Our method is based on the ability of phenylboronate agarose (PBA) to form reversible complexes with 1,2-cis-diol-containing molecules, like sugars in glycoproteins. Finding that additional factors (i.e., ionic and hydrophobic interactions) contribute to the Epo-PBA binding reaction, chromatography conditions have been optimized in scale-down experiments to improve selectivity and yield. As a result, the high performance of affinity chromatography has been achieved using a support possessing the robustness, chemical stability and low cost of a small synthetic ligand. By adding an anion exchange chromatography step and gel filtration for polishing, a pure and active product can easily be obtained by an integrated, start-to-end process optimized for industrial-scale operations.

Original languageEnglish
Pages (from-to)275-287
Number of pages13
JournalJournal of Biotechnology
Volume101
Issue number3
DOIs
Publication statusPublished - Mar 20 2003

Fingerprint

Erythropoietin
Cell culture
Sepharose
Purification
Cell Culture Techniques
Chromatography
Costs and Cost Analysis
Glycosylation
Affinity chromatography
Costs
Glycoproteins
Chemical stability
Biotechnology
Polishing
Sugars
Ion exchange
Sales
N-Acetylneuraminic Acid
Negative ions
Gels

Keywords

  • Affinity chromatography
  • Downstream processing
  • PBA
  • Urea

ASJC Scopus subject areas

  • Biotechnology

Cite this

Evaluation of phenylboronate agarose for industrial-scale purification of erythropoietin from mammalian cell cultures. / Zanette, Dino; Soffientini, Adolfo; Sottani, Cristina; Sarubbi, Edoardo.

In: Journal of Biotechnology, Vol. 101, No. 3, 20.03.2003, p. 275-287.

Research output: Contribution to journalArticle

@article{8c8642f10c004675b353a749b76d1f57,
title = "Evaluation of phenylboronate agarose for industrial-scale purification of erythropoietin from mammalian cell cultures",
abstract = "The search for novel, cost-effective ways to produce erythropoietin (Epo), the world top-selling biopharmaceutical, is a major challenge for today's biotechnology industry. However, Epo's high glycosylation content (almost 40{\%} of total mass) and the requirement for sialic acid for optimal in vivo activity still make mammalian cells the expression system of choice. In contrast to the abundance of reports on Epo production, robust, cost-effective methods for large-scale Epo purification can hardly be found in literature. To fill this gap, we describe here a process specifically studied for industrial-scale purification of the protein. Our method is based on the ability of phenylboronate agarose (PBA) to form reversible complexes with 1,2-cis-diol-containing molecules, like sugars in glycoproteins. Finding that additional factors (i.e., ionic and hydrophobic interactions) contribute to the Epo-PBA binding reaction, chromatography conditions have been optimized in scale-down experiments to improve selectivity and yield. As a result, the high performance of affinity chromatography has been achieved using a support possessing the robustness, chemical stability and low cost of a small synthetic ligand. By adding an anion exchange chromatography step and gel filtration for polishing, a pure and active product can easily be obtained by an integrated, start-to-end process optimized for industrial-scale operations.",
keywords = "Affinity chromatography, Downstream processing, PBA, Urea",
author = "Dino Zanette and Adolfo Soffientini and Cristina Sottani and Edoardo Sarubbi",
year = "2003",
month = "3",
day = "20",
doi = "10.1016/S0168-1656(02)00357-7",
language = "English",
volume = "101",
pages = "275--287",
journal = "Journal of Biotechnology",
issn = "0168-1656",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Evaluation of phenylboronate agarose for industrial-scale purification of erythropoietin from mammalian cell cultures

AU - Zanette, Dino

AU - Soffientini, Adolfo

AU - Sottani, Cristina

AU - Sarubbi, Edoardo

PY - 2003/3/20

Y1 - 2003/3/20

N2 - The search for novel, cost-effective ways to produce erythropoietin (Epo), the world top-selling biopharmaceutical, is a major challenge for today's biotechnology industry. However, Epo's high glycosylation content (almost 40% of total mass) and the requirement for sialic acid for optimal in vivo activity still make mammalian cells the expression system of choice. In contrast to the abundance of reports on Epo production, robust, cost-effective methods for large-scale Epo purification can hardly be found in literature. To fill this gap, we describe here a process specifically studied for industrial-scale purification of the protein. Our method is based on the ability of phenylboronate agarose (PBA) to form reversible complexes with 1,2-cis-diol-containing molecules, like sugars in glycoproteins. Finding that additional factors (i.e., ionic and hydrophobic interactions) contribute to the Epo-PBA binding reaction, chromatography conditions have been optimized in scale-down experiments to improve selectivity and yield. As a result, the high performance of affinity chromatography has been achieved using a support possessing the robustness, chemical stability and low cost of a small synthetic ligand. By adding an anion exchange chromatography step and gel filtration for polishing, a pure and active product can easily be obtained by an integrated, start-to-end process optimized for industrial-scale operations.

AB - The search for novel, cost-effective ways to produce erythropoietin (Epo), the world top-selling biopharmaceutical, is a major challenge for today's biotechnology industry. However, Epo's high glycosylation content (almost 40% of total mass) and the requirement for sialic acid for optimal in vivo activity still make mammalian cells the expression system of choice. In contrast to the abundance of reports on Epo production, robust, cost-effective methods for large-scale Epo purification can hardly be found in literature. To fill this gap, we describe here a process specifically studied for industrial-scale purification of the protein. Our method is based on the ability of phenylboronate agarose (PBA) to form reversible complexes with 1,2-cis-diol-containing molecules, like sugars in glycoproteins. Finding that additional factors (i.e., ionic and hydrophobic interactions) contribute to the Epo-PBA binding reaction, chromatography conditions have been optimized in scale-down experiments to improve selectivity and yield. As a result, the high performance of affinity chromatography has been achieved using a support possessing the robustness, chemical stability and low cost of a small synthetic ligand. By adding an anion exchange chromatography step and gel filtration for polishing, a pure and active product can easily be obtained by an integrated, start-to-end process optimized for industrial-scale operations.

KW - Affinity chromatography

KW - Downstream processing

KW - PBA

KW - Urea

UR - http://www.scopus.com/inward/record.url?scp=0037457414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037457414&partnerID=8YFLogxK

U2 - 10.1016/S0168-1656(02)00357-7

DO - 10.1016/S0168-1656(02)00357-7

M3 - Article

C2 - 12615396

AN - SCOPUS:0037457414

VL - 101

SP - 275

EP - 287

JO - Journal of Biotechnology

JF - Journal of Biotechnology

SN - 0168-1656

IS - 3

ER -